Antitumor effectiveness of a combined therapy with a new cucurbitacin B derivative and paclitaxel on a human lung cancer xenograft model

Non-small cell lung cancer (NSCLC) is one of the most common malignant tumors, with a high mortality rate due to the elevated risk of resistance. Natural cucurbitacins and their derivatives are recognized as promising antitumor compounds for several types of cancer, including NSCLC. In a recent stud...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marostica, L.L., de Barros, A.L.B., Oliveira, J., Salgado, B.S., Cassali, G.D., Leite, E.A., Cardoso, V.N., Lang, K.L., Caro, M.S.B., Durán, F.J., Schenkel, E.P., de Oliveira, M.C., Simões, C.M.O.
Formato: JOUR
Materias:
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_0041008X_v329_n_p272_Marostica
Aporte de:

Ejemplares similares